⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 8, 2024Lara D. Veeken

The OMERACT giant cell arteritis ultrasonography score: a potential predictive outcome for assessing the risk of relapse during follow-up

J. Molina Collada I. Monjo Elisa Fernández-Fernández José María Álvaro‐Gracia Eugenio de Miguel

View Full Paper

Ask AI

Bookmark

Share

Abstract

To determine whether the OMERACT giant cell arteritis (GCA) Ultrasonography (US) Score (OGUS) change after treatment can be used for assessing the probability of relapse.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Collada et al. (2024) studied this question.

synapsesocial.com/papers/68e6b01bb6db64358763160c https://doi.org/10.1093/rheumatology/keae260

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1OP0309 THE GIANT CELL ARTERITIS (GCA) ULTRASOUND SCORE (OGUS) AT DIAGNOSIS AND AFTER INITIAL TREATMENT PREDICTS FUTURE RELAPSES IN GCA PATIENTS: RESULTS FROM A PROSPECTIVE MULTICENTRE STUDY2024 · 3 citations
2Prognostic value of quantifying vascular inflammation through ultrasound in patients with giant cell arteritis: the MAGiCUS studyObservational Study · 2026
3A prospective cohort study evaluating the role of quantifying sonographic inflammatory changes in giant cell arteritis2025 · 1 citations
4POS0930 UTILITY OF ULTRASOUND MONITORING GIANT CELL ARTERITIS LARGE VESSEL IN CLINICAL PRACTICE2024
5Dynamic vascular changes on long-term ultrasound monitoring predict relapse in large-vessel giant cell arteritisLongitudinal Study · 2026 · 1 citations